{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T10:14:18Z","timestamp":1778753658691,"version":"3.51.4"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"DOI":"10.1007\/s00277-026-07027-8","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T07:23:42Z","timestamp":1777447422000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Allogeneic versus autologous transplantation in multiple myeloma: reduced relapse at the cost of higher non-relapse mortality in a large single-center cohort"],"prefix":"10.1007","volume":"105","author":[{"given":"Sahar","family":"Tavakoli Shiraji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Biglari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Barkhordar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghazal","family":"Seghatoleslami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghasem","family":"Janbabai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davood","family":"Babakhani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marjan","family":"Yaghmaie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soroush","family":"Rad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Vaezi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamran","family":"Alimoghadam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hosein Kamranzadeh","family":"Fumani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seied Asadollah","family":"Mousavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ardeshir","family":"Ghavamzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"issue":"1","key":"7027_CR1","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1182\/hematology.2022000347","volume":"2022","author":"TM Schmidt","year":"2022","unstructured":"Schmidt TM (2022) High or low? Assessing disease risk in multiple myeloma. Hematol Am Soc Hematol Educ Program 2022(1):349\u2013355","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"9","key":"7027_CR2","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1001\/jamaoncol.2018.2128","volume":"4","author":"AJ Cowan","year":"2018","unstructured":"Cowan AJ et al (2018) Global Burden of Multiple Myeloma: A Systematic Analysis for the Global Burden of Disease Study 2016. JAMA Oncol 4(9):1221\u20131227","journal-title":"JAMA Oncol"},{"issue":"1","key":"7027_CR3","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1186\/s12885-021-08280-y","volume":"21","author":"L Zhou","year":"2021","unstructured":"Zhou L et al (2021) Measuring the global, regional, and national burden of multiple myeloma from 1990 to 2019. BMC Cancer 21(1):606","journal-title":"BMC Cancer"},{"issue":"1","key":"7027_CR4","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1186\/s12885-023-10907-1","volume":"23","author":"CM Lin","year":"2023","unstructured":"Lin CM et al (2023) Treatment benefit of upfront autologous stem cell transplantation for newly diagnosed multiple myeloma: a systematic review and meta-analysis. BMC Cancer 23(1):446","journal-title":"BMC Cancer"},{"issue":"2","key":"7027_CR5","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1182\/bloodadvances.2019000524","volume":"4","author":"KK Nishimura","year":"2020","unstructured":"Nishimura KK et al (2020) Long-term outcomes after autologous stem cell transplantation for multiple myeloma. Blood Adv 4(2):422\u2013431","journal-title":"Blood Adv"},{"issue":"3","key":"7027_CR6","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1001\/jamaoncol.2017.4600","volume":"4","author":"B Dhakal","year":"2018","unstructured":"Dhakal B et al (2018) Autologous Transplantation for Newly Diagnosed Multiple Myeloma in the Era of Novel Agent Induction: A Systematic Review and Meta-analysis. JAMA Oncol 4(3):343\u2013350","journal-title":"JAMA Oncol"},{"issue":"6","key":"7027_CR7","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1080\/10428194.2018.1543874","volume":"60","author":"B Su","year":"2019","unstructured":"Su B et al (2019) A meta-analysis of autologous transplantation for newly diagnosed multiple myeloma in the era of novel agents. Leuk Lymphoma 60(6):1381\u20131388","journal-title":"Leuk Lymphoma"},{"key":"7027_CR8","doi-asserted-by":"publisher","first-page":"1402106","DOI":"10.3389\/fonc.2024.1402106","volume":"14","author":"C Liberatore","year":"2024","unstructured":"Liberatore C, Fioritoni F, Di M, Ianni (2024) Allogeneic stem cell transplantation in multiple myeloma: is there still a place? Front Oncol 14:1402106","journal-title":"Front Oncol"},{"issue":"7","key":"7027_CR9","first-page":"409e1","volume":"28","author":"R Phelan","year":"2022","unstructured":"Phelan R et al (2022) Updated Trends in Hematopoietic Cell Transplantation in the United States with an Additional Focus on Adolescent and Young Adult Transplantation Activity and Outcomes. Transpl Cell Ther 28(7):409e1\u2013409e10","journal-title":"Transpl Cell Ther"},{"issue":"7","key":"7027_CR10","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1038\/s41409-021-01227-8","volume":"56","author":"JR Passweg","year":"2021","unstructured":"Passweg JR et al (2021) Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years. Bone Marrow Transpl 56(7):1651\u20131664","journal-title":"Bone Marrow Transpl"},{"key":"7027_CR11","doi-asserted-by":"crossref","unstructured":"Puertas B et al (2023) Novel agents as main drivers for continued improvement in survival in multiple myeloma. Cancers (Basel) 15(5)","DOI":"10.3390\/cancers15051558"},{"key":"7027_CR12","doi-asserted-by":"publisher","first-page":"1339605","DOI":"10.3389\/fonc.2024.1339605","volume":"14","author":"M Azari","year":"2024","unstructured":"Azari M et al (2024) Determining the predictive impact of donor parity on the outcomes of human leukocyte antigen matched hematopoietic stem cell transplants: a retrospective, single-center study. Front Oncol 14:1339605","journal-title":"Front Oncol"},{"issue":"1","key":"7027_CR13","first-page":"51","volume":"15","author":"M Barkhordar","year":"2021","unstructured":"Barkhordar M et al (2021) Selection of Suitable Alternative Donor in the Absence of Matched Sibling Donor: A Retrospective Single-Center Study to Compare between Haploidentical, 10\/10 and 9\/10 Unrelated Donor Transplantation. Int J Hematol Oncol Stem Cell Res 15(1):51\u201360","journal-title":"Int J Hematol Oncol Stem Cell Res"},{"issue":"6","key":"7027_CR14","first-page":"825","volume":"15","author":"D Przepiorka","year":"1995","unstructured":"Przepiorka D et al (1995) 1994 Consensus conference on acute GVHD grading. Bone Marrow Transp 15(6):825\u2013828","journal-title":"Bone Marrow Transp"},{"issue":"3","key":"7027_CR15","first-page":"250","volume":"28","author":"KM Sullivan","year":"1991","unstructured":"Sullivan KM et al (1991) Chronic graft-versus-host disease and other late complications of bone marrow transplantation. Semin Hematol 28(3):250\u2013259","journal-title":"Semin Hematol"},{"issue":"13","key":"7027_CR16","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1016\/S1470-2045(11)70243-1","volume":"12","author":"A Krishnan","year":"2011","unstructured":"Krishnan A et al (2011) Autologous haemopoietic stem-cell transplantation followed by allogeneic or autologous haemopoietic stem-cell transplantation in patients with multiple myeloma (BMT CTN 0102): a phase 3 biological assignment trial. Lancet Oncol 12(13):1195\u20131203","journal-title":"Lancet Oncol"},{"issue":"11","key":"7027_CR17","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1056\/NEJMoa065464","volume":"356","author":"B Bruno","year":"2007","unstructured":"Bruno B et al (2007) A comparison of allografting with autografting for newly diagnosed myeloma. N Engl J Med 356(11):1110\u20131120","journal-title":"N Engl J Med"},{"issue":"6","key":"7027_CR18","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1200\/JCO.1995.13.6.1312","volume":"13","author":"G Gahrton","year":"1995","unstructured":"Gahrton G et al (1995) Prognostic factors in allogeneic bone marrow transplantation for multiple myeloma. J Clin Oncol 13(6):1312\u20131322","journal-title":"J Clin Oncol"},{"issue":"1","key":"7027_CR19","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3390\/cancers14010055","volume":"14","author":"N Gagelmann","year":"2021","unstructured":"Gagelmann N, Eikema DJ, Iacobelli S (2021) Allogeneic stem cell transplantation in multiple myeloma: a retrospective study from the EBMT Chronic Malignancies Working Party. Cancers (Basel) 14(1):55","journal-title":"Cancers (Basel)"},{"issue":"11","key":"7027_CR20","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1038\/s41375-019-0537-2","volume":"33","author":"B Dhakal","year":"2019","unstructured":"Dhakal B, D\u2019Souza A, Fenske TS (2019) Allogeneic hematopoietic cell transplantation in multiple myeloma: trends and outcomes in the era of novel therapies. Leukemia 33(11):2710\u20132719","journal-title":"Leukemia"},{"key":"7027_CR21","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12935-018-0553-8","volume":"18","author":"X Yin","year":"2018","unstructured":"Yin X et al (2018) Allogeneic stem-cell transplantation for multiple myeloma: a systematic review and meta-analysis from 2007 to 2017. Cancer Cell Int 18:62","journal-title":"Cancer Cell Int"},{"issue":"2","key":"7027_CR22","doi-asserted-by":"publisher","first-page":"370","DOI":"10.3324\/haematol.2018.200881","volume":"104","author":"C Greil","year":"2019","unstructured":"Greil C et al (2019) Allogeneic transplantation of multiple myeloma patients may allow long-term survival in carefully selected patients with acceptable toxicity and preserved quality of life. Haematologica 104(2):370\u2013379","journal-title":"Haematologica"}],"updated-by":[{"DOI":"10.1007\/s00277-026-07065-2","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000}}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-07027-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-026-07027-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-07027-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T09:22:44Z","timestamp":1778750564000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-026-07027-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":22,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["7027"],"URL":"https:\/\/doi.org\/10.1007\/s00277-026-07027-8","relation":{},"ISSN":["1432-0584"],"issn-type":[{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]},"assertion":[{"value":"30 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00277-026-07065-2","URL":"https:\/\/doi.org\/10.1007\/s00277-026-07065-2","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Conducted according to the Declaration of Helsinki. Ethics approval was waived due to retrospective anonymized design.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"273"}}